| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.22 | 3e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.16 | 0.0009 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.094 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.084 | 0.08 |